Oxxon Therapeutics' Unattributed VC Round

Oxxon Therapeutics raised a round of funding on April 21, 2003.

Oxxon Therapeutics is a mid-stage biotechnology company developing a portfolio of immunotherapeutics for infectious disease and cancer in man using its proprietary Heterologous PrimeBoost approach. Th…

Articles about Oxxon Therapeutics' Unattributed VC Round: